Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells

被引:16
|
作者
Yu, D. -S. [1 ]
Hsieh, D. S. [1 ]
Chang, S. Y. [1 ]
机构
[1] TriServ Gen Hosp, Natl Def Med Ctr, Dept Surg, Urooncol Lab, Taipei, Taiwan
来源
ARCHIVES OF ANDROLOGY | 2006年 / 52卷 / 04期
关键词
prostate cancer; chemoresistance-associated proteins; MIF; ID1; GST-pi;
D O I
10.1080/01485010600630124
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The differential expression of genes and related proteins of multidrug resistance in chemoresistant prostate cancer cell lines were elucidated in this study. RNA extracted from doxorubicin-resistant rat prostate cancer (PCa) cells (AT3/ADR1000) and native PCa cells was hybridized to expression arrays containing cDNAs from 588 known genes. Differential expression of selected genes was confirmed by quantitative reverse-transcription polymerase chain reaction (RT-PCR) analysis. Protein contents were measured by fluorescent flow cytometry and immunoblotting. Localization of selected proteins in cells was observed by immunocytochemical staining. Up-regulation of eleven genes and down-regulation of one single gene were displayed in the chemoresistant prostate cancer cells. Overexpression of mRNAs in macrophage migration inhibitory factor (MIF), DNA binding protein inhibitor 1 (ID1), and glutathione S-transferase-pi (GST-pi) were confirmed by gene-specific RT-PCR. Protein over-expression of GST-pi, MIF, and ID1 in resistant cells were 3.3-, 1.5-, and 1.5-fold to native cells, respectively. Immunocytochemistry revealed that GST-pi, MIF, and ID1 were present primarily in the cytoplasm of tumor cells, but ID1 also could be found in the nucleus. AT3/ADR1000 drug-resistant PCa cells displayed significantly increased expression of GST-pi, MIF, and ID1 proteins when compared with native PCa cells. It indicates these genes may play a role in drug resistance of prostate cancer.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 50 条
  • [1] Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice
    Naiki, Taku
    Asamoto, Makoto
    Toyoda-Hokaiwado, Naomi
    Naiki-Ito, Aya
    Tozawa, Keiichi
    Kohri, Kenjiro
    Takahashi, Satoru
    Shirai, Tomoyuki
    PROSTATE, 2012, 72 (05): : 533 - 541
  • [2] Release of GST-pi promoter hypermethylation and activity of brostallicin in human prostate cancer cells
    Sabatino, MA
    Geroni, C
    Broggini, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S31 - S31
  • [3] c-Jun and GST-pi expression in human plasma cells
    DiSimone, D
    Galimberti, S
    Mattii, L
    Petrini, M
    HAEMATOLOGICA, 1997, 82 (01) : 69 - 70
  • [4] Prostate cancer: The Id1 story
    Wong, YC
    Wang, XH
    Ling, MT
    Ouyang, XS
    Chan, FL
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2004, 37 (06) : 331 - 337
  • [5] EXPRESSION OF GST-PI IN GASTRIC-CANCER TISSUES AND PRENEOPLASTIC LESIONS
    QI, CH
    GUO, SC
    ZHANG, L
    LU, YF
    LI, CH
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1994, 9 (03): : 25 - 29
  • [6] GST-pi expression correlates with oxidative stress and apoptosis in breast cancer
    Huang, JX
    Tan, PH
    Tan, BKH
    Bay, BH
    ONCOLOGY REPORTS, 2004, 12 (04) : 921 - 925
  • [7] Organ Specific Gst-pi Expression in New Metastatic Androgen-Independent Prostate Cancer Animal Model
    Naiki, T.
    Asamoto, M.
    Naiki-Ito, A.
    Kawai, N.
    Tozawa, K.
    Takahashi, S.
    Kohri, K.
    UROLOGY, 2012, 80 (03) : S277 - S277
  • [8] Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
    Sharma, Pankaj
    Patel, Divya
    Chaudhary, Jaideep
    CANCER MEDICINE, 2012, 1 (02): : 187 - 197
  • [9] Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue
    Cookson, MS
    Reuter, VE
    Linkov, I
    Fair, WR
    JOURNAL OF UROLOGY, 1997, 157 (02): : 673 - 676
  • [10] Organ-specific Gst-pi expression in new metastatic androgen-independent prostate cancer animal model
    Naiki, Taku
    Asamoto, Makoto
    Naiki-Ito, Aya
    Yamada, Kenji
    Ando, Ryosuke
    Ikegami, Youichi
    Kawai, Noriyasu
    Tozawa, Keiichi
    Takahashi, Satoru
    Kohri, Kenjiro
    CANCER RESEARCH, 2012, 72